Crossmark

On the Pharmaceutical Development of a Liposomal Dosage Form of a Tyrosine Kinase Inhibitor

Published Online: 2025-08-25

Published Print: 2025-06

Authors

Shprakh, Z. S.

Kovaleva, A. R.

Sanarova, E. V.

Kozin, D. A.

Nikolaeva, L. L.
License Information

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-06-01
More Information

Article History

Received: 8 October 2024

Revised: 28 January 2025

Accepted: 28 January 2025

First Online: 25 August 2025

CONFLICT OF INTEREST

: The authors of this work declare that they have no conflicts of interest.

Document is current